News Merck funds Antidote's clinical trial matching tech Funding will go toward expansion of platform capabilities.
Views & Analysis Digital Health Round-up: Microsoft to ‘solve’ cancer and mor... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
